VIVOBIOT stock news
This page provides real-time market news, earnings updates, and company announcements related to Vivo Bio Tech Ltd. (VIVOBIOT).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-17 21:31 IST
Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates
Finviz2026-03-09 11:03:50
Tenaya Therapeutics Presents Preclinical Data at MDA 2026 Highlighting TN-301's Potential to Correct Skeletal and Cardiac Muscle Decline in Duchenne Muscular Dystrophy
Finviz2026-03-09 12:34:02
Actuate Therapeutics Launches Strategic Research Initiative to Combine Elraglusib with RAS Inhibitors
Finviz2026-03-09 12:48:57
Tenaya Therapeutics Presents Preclinical Data at MDA 2026 Highlighting TN-301's Potential to Correct Skeletal and Cardiac Muscle Decline in Duchenne Muscular Dystrophy
Finviz2026-03-09 12:34:02
AN2 Therapeutics Stock Jumps 90% Monday: What's Driving The Action?
Finviz2026-03-09 18:51:48
Erasca Exercises Option to Secure Worldwide Rights for ERAS-0015 Pan-RAS Molecular Glue to Include China, Hong Kong, and Macau
Finviz2026-03-10 12:03:12
VivoPower Announces New Stock Ticker "VIVO" and Corporate Name Change in Alignment with its Business Focus on AI Data Centers
Finviz2026-03-10 13:25:03
VivoPower officially announces that its stock trading code will be changed to "Vivo", and the company name will also be adjusted accordingly.
老虎证券2026-03-10 14:34:04
Mr. Duan has also invested in AI
金融界2026-03-11 10:21:44
GLW Benefits From Robust Specialty Materials Segment: Can This Momentum Continue?
101 finance2026-03-11 17:04:03
Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook
Finviz2026-03-11 20:12:54
Korro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-03-12 20:09:50
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Finviz2026-03-13 13:03:11
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Finviz2026-03-13 13:03:11
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Finviz2026-03-13 13:03:11
Weekly Hot Picks: Will Oil Release Solve the Hormuz Dilemma? Iran's Supreme Leader Makes Tough Statement for the First Time
金十数据2026-03-13 14:05:25
OmniAb (OABI) Fourth Quarter 2025 Earnings Conference Call Transcript
101 finance2026-03-15 04:39:34
Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio
Finviz2026-03-16 10:33:49
VivoPower Announces Effectiveness of New Stock Ticker "VIVO" and Corporate Name Change
Finviz2026-03-16 11:09:04
Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices
Finviz2026-03-16 11:24:49
HCW Biologics Announces Positive Research Results for CAR-T Cell Therapy Manufactured Utilizing Its Commercial-Ready Proprietary Compound, HCW9206, Published in Science Advances
Finviz2026-03-16 12:03:48
Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Finviz2026-03-16 20:09:45
iBio to Provide an Update on Cardiopulmonary Program Targeting Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
Finviz2026-03-16 20:33:54
Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery, Biomarker Research, and Novel Antibodies at Advances in Alzheimer's Treatment at International Conference on Alzheimer's and Parkinson's Diseases 2026
Finviz2026-03-17 12:03:54
AN2 Therapeutics Stock Jumps 90% Monday: What's Driving The Action?
Finviz2026-03-09 18:51:48
Erasca Exercises Option to Secure Worldwide Rights for ERAS-0015 Pan-RAS Molecular Glue to Include China, Hong Kong, and Macau
Finviz2026-03-10 12:03:12
VivoPower Announces New Stock Ticker "VIVO" and Corporate Name Change in Alignment with its Business Focus on AI Data Centers
Finviz2026-03-10 13:25:03
VivoPower officially announces that its stock trading code will be changed to "Vivo", and the company name will also be adjusted accordingly.
老虎证券2026-03-10 14:34:04
Mr. Duan has also invested in AI
金融界2026-03-11 10:21:44
GLW Benefits From Robust Specialty Materials Segment: Can This Momentum Continue?
101 finance2026-03-11 17:04:03
Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook
Finviz2026-03-11 20:12:54
Korro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-03-12 20:09:50
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Finviz2026-03-13 13:03:11
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Finviz2026-03-13 13:03:11
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Finviz2026-03-13 13:03:11
Weekly Hot Picks: Will Oil Release Solve the Hormuz Dilemma? Iran's Supreme Leader Makes Tough Statement for the First Time
金十数据2026-03-13 14:05:25
OmniAb (OABI) Fourth Quarter 2025 Earnings Conference Call Transcript
101 finance2026-03-15 04:39:34
Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio
Finviz2026-03-16 10:33:49
VivoPower Announces Effectiveness of New Stock Ticker "VIVO" and Corporate Name Change
Finviz2026-03-16 11:09:04
Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices
Finviz2026-03-16 11:24:49
HCW Biologics Announces Positive Research Results for CAR-T Cell Therapy Manufactured Utilizing Its Commercial-Ready Proprietary Compound, HCW9206, Published in Science Advances
Finviz2026-03-16 12:03:48
Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Finviz2026-03-16 20:09:45
iBio to Provide an Update on Cardiopulmonary Program Targeting Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
Finviz2026-03-16 20:33:54
Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery, Biomarker Research, and Novel Antibodies at Advances in Alzheimer's Treatment at International Conference on Alzheimer's and Parkinson's Diseases 2026
Finviz2026-03-17 12:03:54
VIVOBIOT stock price change
On the last trading day, VIVOBIOT stock closed at 24.35 INR, with a price change of 0.58% for the day.
Trade stock perpsVIVOBIOT stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more